Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Rudolf M. Huber"'
Autor:
Clemens Aigner, Hasan Batirel, Rudolf M. Huber, David R. Jones, Alan D.L. Sihoe, Tomaž Štupnik, Alessandro Brunelli
Publikováno v:
European Respiratory Review, Vol 33, Iss 171 (2024)
Surgery remains an essential element of the multimodality radical treatment of patients with early-stage nonsmall cell lung cancer. In addition, thoracic surgery is one of the key specialties involved in the lung cancer tumour board. The importance o
Externí odkaz:
https://doaj.org/article/2463c732387d4ae4aac9d310a2ae1853
Autor:
Scott N. Gettinger, MD, Rudolf M. Huber, MD, PhD, Dong-Wan Kim, MD, PhD, Lyudmila Bazhenova, MD, Karin Holmskov Hansen, MD, Marcello Tiseo, MD, Corey J. Langer, MD, FACP, Luis G. Paz-Ares Rodríguez, MD, PhD, Howard L. West, MD, Karen L. Reckamp, MD, MS, Glen J. Weiss, MD, Egbert F. Smit, MD, PhD, Maximilian J. Hochmair, MD, Sang-We Kim, MD, PhD, Myung-Ju Ahn, MD, PhD, Edward S. Kim, MD, FACP, Harry J.M. Groen, MD, PhD, Joanna Pye, MS, Yuyin Liu, PhD, Pingkuan Zhang, MD, Florin Vranceanu, MD, PhD, D. Ross Camidge, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 9, Pp 100385- (2022)
Introduction: We report brigatinib long-term efficacy and safety from phase 1/2 and phase 2 (ALTA) trials in ALK–rearrangement positive (ALK+) NSCLC. Methods: The phase 1/2 study evaluated brigatinib 30 to 300 mg/d in patients with advanced maligna
Externí odkaz:
https://doaj.org/article/78d40f5a880944a8b24323de142222e5
Autor:
Wouter H. van Geffen, Torsten G. Blum, Stefano Aliberti, Kevin G. Blyth, Clementine Bostantzoglou, Amy Farr, Bogdan Grigoriu, Georgia Hardavella, Rudolf M. Huber, Nick Maskell, Gilbert Massard, Najib M. Rahman, Daiana Stolz, Jan van Meerbeeck
Publikováno v:
Breathe, Vol 15, Iss 4, Pp 279-285 (2019)
Externí odkaz:
https://doaj.org/article/08e2f690cbac421f9473c6607c466124
Autor:
Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber, Jürgen Behr, Frank Biertz, Henrik Watz, Robert Bals, Claus F. Vogelmeier, Rudolf A. Jörres
Publikováno v:
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Recent investigations showed single associations between uric acid levels, functional parameters, exacerbations and mortality in COPD patients. The aim of this study was to describe the role of uric acid within the network of mult
Externí odkaz:
https://doaj.org/article/84439401edda4a97844a0a4c228a67a1
Autor:
Stefan Karrasch, Jürgen Behr, Rudolf M. Huber, Dennis Nowak, Annette Peters, Stefan Peters, Rolf Holle, Rudolf A. Jörres, Holger Schulz, KORA Study Group
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background The relationship of spirometric values to other respiratory and functional parameters in advanced age is not well studied. We assessed this relationship in elderly subjects with either good or poor spirometric parameters to reveal
Externí odkaz:
https://doaj.org/article/ffd765f75496445d92ae9be63c2df97e
Publikováno v:
European Respiratory Review, Vol 28, Iss 152 (2019)
Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very heterogeneous with varying and mostly poor prognosis. It is also called “locoregionally or locally advanced disease”. Due to its heterogeneity a g
Externí odkaz:
https://doaj.org/article/7288f0c726974bb5bad645b484460918
Autor:
Fernando Gamarra, Julie-Lyn Noël, Alessandro Brunelli, Anne-Marie C. Dingemans, Enriqueta Felip, Mina Gaga, Bogdan Dragos Grigoriu, Georgia Hardavella, Rudolf M. Huber, Samuel Janes, Gilbert Massard, Paul Martin Putora, Jean-Paul Sculier, Philipp A. Schnabel, Sara Ramella, Dirk Van Raemdonck, Anne-Pascale Meert
Publikováno v:
Breathe, Vol 12, Iss 3, Pp 249-255 (2016)
Externí odkaz:
https://doaj.org/article/eeadb3d275cc4e6cafcbc657bc58f129
Autor:
Anna Kerpel-Fronius, Martin Tammemägi, Milena Cavic, Claudia Henschke, Long Jiang, Ella Kazerooni, Choon-Taek Lee, Luigi Ventura, Dawei Yang, Stephen Lam, Rudolf M. Huber, Javier Zulueta, Lucia Viola, Anant Mohan, Heidi Schmidt, Ricardo Sales dos Santos, Gabriella Sozzi, Rudolf Huber
Publikováno v:
Journal of Thoracic Oncology. 17:56-66
Screening with low-dose computed tomography of high-risk individuals with a smoking history reduces lung cancer mortality. Current screening guidelines and eligibility criteria can miss more than 50% of lung cancers, and in some geographic areas, suc
Autor:
Andreas Jung, Diego Kauffmann-Guerrero, L Sellmer, Pontus Mertsch, Farkhad Manapov, Rudolf M. Huber, Amanda Tufman, Sabine Semrau, Jens Neumann, Astrid Borgmeier, Bernhard Ulm, Rainer Fietkau, Kathrin Kahnert, Achim Rittmeyer, Kurt Ulm, Michael Flentje
Publikováno v:
Lung Cancer. 160:17-27
Immune checkpoint inhibition after radiochemotherapy (RTCT) has become a new standard of care for locally advanced non-small cell lung cancer with programmed death-ligand 1 (PD-L1) expression. However, little is known about the prognostic role of imm
Autor:
Rudolf M. Huber, Frank Biertz, Joachim Heinrich, Henrik Watz, Jørgen Vestbo, Rudolf A. Jörres, Kathrin Kahnert, Jürgen Behr, Felix J.F. Herth, Tobias Welte, Tanja Lucke, Emiel F.M. Wouters, Claus F. Vogelmeier, David Young, Peter Alter, Hubert Wirtz, Margarethe Wacker, Robert Bals
Publikováno v:
Respiratory Medicine, 134, 79-85. Elsevier Saunders
Respir. Med. 134, 79-85 (2018)
Respir. Med. 134, 79-85 (2018)
Introduction The COPD classification proposed by the Global Initiative for Obstructive Lung Disease was recently revised, and the A to D grouping is now based on symptoms and exacerbations only. Potential associations with comorbidities have not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29387c3e473e37b40be8fc6f5b903abb